企業プロフィール
BioVie Inc. 株価・ニュース・カタリスト
- ティッカー:
- BIVI
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.95 USD (+4.84%)
終値
最終更新: 2026年8月21日
12.8M USD
時価総額
株価変動の要因
As of Aug 21, 2026, BIVI closed up 4.84% at $1.95. No new same-company headline was identified in the current news window.
企業概要
事業概要
BioVie is a biotechnology company focused on neurodegeneration, inflammation, and chronic disease biology. Its story has centered on trying to build a therapeutic platform in areas with large unmet need but high development risk.
所在地とセクター分類
BioVie is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
ビジネスモデルの特徴
The company depends on clinical progress, strategic focus, and financing discipline. Investors usually watch early data, pipeline direction, and whether the company can preserve enough runway.
バイオ業界での位置付け
BioVie occupies a speculative small-cap biotech niche. It is a catalyst-sensitive story where the market is still waiting for a clear clinical breakthrough.
今後のカタリスト
- BioVie’s catalysts are azeliragon-related programs and any strategic or clinical update that clarifies the company’s path. The next step matters because the company still needs a strong human-data signal.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。